146 related articles for article (PubMed ID: 700900)
1. Oncogenicity of Friend-virus-infected cells: determination of origin of spleen colonies by the H-2 antigens as genetic markers.
Wendling F; Tambourin PE
Int J Cancer; 1978 Oct; 22(4):479-86. PubMed ID: 700900
[TBL] [Abstract][Full Text] [Related]
2. Incapacity of hematopoietic stem cell-deprived mice to produce tumor colonies induced by Friend virus-infected cells.
Wendling F; Tambourin P; Moreau-Gachelin F
Exp Hematol; 1978 Nov; 6(10):777-84. PubMed ID: 744202
[TBL] [Abstract][Full Text] [Related]
3. Evidence for transformation of spleen cells one day after infection of mice with friend leukemia virus.
Rossi GB; Gudkowicz G; Friend C
J Exp Med; 1970 Apr; 131(4):765-81. PubMed ID: 4914375
[TBL] [Abstract][Full Text] [Related]
4. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of murine leukemia. XI. differential susceptibility of spleen cells from serum-protected mice to the in vitro immunosuppressive effects of Friend leukemia virus-infected splenocytes.
Pettey CL; Collins JJ
Int J Cancer; 1984 Aug; 34(2):269-76. PubMed ID: 6540757
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of genetic resistance to friend virus leukemia in mice.
Kumar V; Bennett M; Eckner RJ
J Exp Med; 1974 May; 139(5):1093-109. PubMed ID: 4596510
[TBL] [Abstract][Full Text] [Related]
7. Quantitative colony method for tumorigenic cells transformed by two distinct strains of Friend leukemia virus.
Mager DL; Mak TW; Bernstein A
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1703-7. PubMed ID: 6940184
[TBL] [Abstract][Full Text] [Related]
8. Relation between Friend leukemia virus-induced leukemia and genetic control of the host.
Kitagawa M; Matsubara O; Kasuga T
Bull Tokyo Med Dent Univ; 1983 Sep; 30(3):95-107. PubMed ID: 6589086
[TBL] [Abstract][Full Text] [Related]
9. Nonrandom inclusion of H-2K and H-2D antigens in Friend virus particles from mice of various strains.
Bubbers JE; Chen S; Lilly F
J Exp Med; 1978 Feb; 147(2):340-51. PubMed ID: 624903
[TBL] [Abstract][Full Text] [Related]
10. Tumor colony formation by Friend virus-infected cells in immunosuppressed mice.
Axeirad AA; Cinader B; Koh SW; van der Gaag HC
Cancer Res; 1976 Jan; 36(1):28-32. PubMed ID: 1248007
[TBL] [Abstract][Full Text] [Related]
11. Origin of spleen colonies generated by Friend virus-infected cells in mice.
Steeves RA; Bubbers JE; Plata F; Lilly F
Cancer Res; 1978 Sep; 38(9):2729-33. PubMed ID: 679178
[No Abstract] [Full Text] [Related]
12. Antibody-induced loss of Friend virus leukemia cell surface antigens occurs during progression of erythroleukemia in F1 mice.
Doig D; Chesebro B
J Exp Med; 1978 Nov; 148(5):1109-21. PubMed ID: 281446
[TBL] [Abstract][Full Text] [Related]
13. Shut-down of virus synthesis during progression of erythroleukemia induced by Friend virus in mice.
Yoosook C
Int J Cancer; 1982 Jun; 29(6):659-65. PubMed ID: 6955290
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
Kitagawa M; Kamisaku H; Aizawa S; Sado T
Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia.
Kitagawa M; Matsubara O; Kasuga T
Cancer Res; 1986 Jun; 46(6):3034-9. PubMed ID: 2870802
[TBL] [Abstract][Full Text] [Related]
16. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Pettey CL; Collins JJ
Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
[TBL] [Abstract][Full Text] [Related]
17. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. I. Virus replication in lymphocytes infected with Friend virus and cultures in diffusion chambers in vivo.
Cerny J; Fistel SH; Hensgen PA
Int J Cancer; 1976 Aug; 18(2):176-88. PubMed ID: 182644
[TBL] [Abstract][Full Text] [Related]
18. Erythroleukemia induction by Friend leukemia virus. A host gene locus controlling early anemia or polycythemia and the rate of proliferation of late erythroid cells.
Shibuya T; Niho Y; Mak TW
J Exp Med; 1982 Aug; 156(2):398-414. PubMed ID: 7097158
[TBL] [Abstract][Full Text] [Related]
19. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
20. Antigenic properties of cultured tumor cell lines derived from spleens of Friend virus-infected BALB/c and BALB/c-H-2b mice.
Freedman HA; Lilly F; Steeves RA
J Exp Med; 1975 Dec; 142(6):1365-76. PubMed ID: 1194854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
